These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23579456)

  • 1. Novel drugs targeting sphingolipid metabolism.
    Bhabak KP; Arenz C
    Handb Exp Pharmacol; 2013; (215):187-96. PubMed ID: 23579456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical tools to investigate sphingolipid metabolism and functions.
    Delgado A; Casas J; Llebaria A; Abad JL; Fabriás G
    ChemMedChem; 2007 May; 2(5):580-606. PubMed ID: 17252619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases.
    Canals D; Perry DM; Jenkins RW; Hannun YA
    Br J Pharmacol; 2011 Jun; 163(4):694-712. PubMed ID: 21615386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional inhibitors of acid sphingomyelinase (FIASMAs).
    Kornhuber J; Tripal P; Gulbins E; Muehlbacher M
    Handb Exp Pharmacol; 2013; (215):169-86. PubMed ID: 23579455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingolipid metabolizing enzymes as novel therapeutic targets.
    Billich A; Baumruker T
    Subcell Biochem; 2008; 49():487-522. PubMed ID: 18751924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology.
    Merrill AH; Schmelz EM; Dillehay DL; Spiegel S; Shayman JA; Schroeder JJ; Riley RT; Voss KA; Wang E
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):208-25. PubMed ID: 9007051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel chemotherapeutic drugs in sphingolipid cancer research.
    Canals D; Hannun YA
    Handb Exp Pharmacol; 2013; (215):211-38. PubMed ID: 23579458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases.
    Adada M; Luberto C; Canals D
    Chem Phys Lipids; 2016 May; 197():45-59. PubMed ID: 26200918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of ceramide and sphingolipid metabolism in tumors: potential modulation of chemotherapy.
    Modrak DE
    Methods Mol Med; 2005; 111():183-94. PubMed ID: 15911980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
    Gatt S; Dagan A
    Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicinal chemistry aspects of drug targets in sphingolipid metabolism.
    Nussbaumer P
    ChemMedChem; 2008 Apr; 3(4):543-51. PubMed ID: 18061920
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of Mycoplasma pneumoniae infection on sphingolipid metabolism in human lung carcinoma A549 cells.
    Yu Y; Sun G; Liu G; Wang Y; Shao Z; Chen Z; Yang J
    Microb Pathog; 2009 Feb; 46(2):63-72. PubMed ID: 19059331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential therapeutic targets for atherosclerosis in sphingolipid metabolism.
    Yu Z; Peng Q; Huang Y
    Clin Sci (Lond); 2019 Mar; 133(6):763-776. PubMed ID: 30890654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingolipid signaling and redox regulation.
    Won JS; Singh I
    Free Radic Biol Med; 2006 Jun; 40(11):1875-88. PubMed ID: 16716889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer compounds and sphingolipid metabolism in the colon.
    Duan RD
    In Vivo; 2005; 19(1):293-300. PubMed ID: 15796189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correction of age-related changes in sphingolipid content in rat tissues by acid sphingomyelinase inhibition].
    Har'kavenko VV; Storozhenko GB; Krasnikova OM; Babenko NO
    Fiziol Zh (1994); 2012; 58(1):56-60. PubMed ID: 22590738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingolipids in the lungs.
    Uhlig S; Gulbins E
    Am J Respir Crit Care Med; 2008 Dec; 178(11):1100-14. PubMed ID: 18755926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingolipids: major regulators of lipid metabolism.
    Worgall TS
    Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):149-55. PubMed ID: 17285002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Entamoeba invadens: sphingolipids metabolic regulation is the main component of a PKC signaling pathway in controlling cell growth and proliferation.
    Cerbon J; Olguin T; Alvarez-Grave PR; López-Sánchez RC
    Exp Parasitol; 2009 Jun; 122(2):106-11. PubMed ID: 19249300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingolipid metabolism and neutral sphingomyelinases.
    Airola MV; Hannun YA
    Handb Exp Pharmacol; 2013; (215):57-76. PubMed ID: 23579449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.